2007 AMLI Annual Meeting 
The Westin
Chicago, Illinois 
August 9-12, 2007

Purpose and Objectives

   The meeting unites professionals engaged in the practice and study of medical laboratory immunology and provides an opportunity to enhance their knowledge of immunologic principles and their application to immune mediated disorders.  Attendees will hear experts in the field present new and cutting-edge information about the pathogenesis, diagnosis, monitoring and treatment of immunological disorders.  This meeting will also highlight new discoveries in immunology and novel and emerging technologies in laboratory medicine.  Finally, this annual meeting offers the individual not only a format for learning but also for collaborations and essential interactions vital to their development and growth.

After attending the meeting, attendees should be able to:

1. Discuss the various immune-based therapies and the current HPV vaccine information and identify strategies for the laboratory monitoring of these immune modulating agents.
2. Discuss the most current laboratory assays used to evaluate transplant and autoimmune patients and discuss advances in therapy and laboratory monitoring for transplant and autoimmune patients.
3. Identify current and emerging technologies to monitor immune mediated diseases.
4. Discuss translational research topics including inflammatory biomarkers of cardiovascular disease & atherosclerosis, role of autoantibodies in cancer, mechanisms of anti-cytokine therapies and impact of nanotechnology to diagnostic testing.
5. Participate in speaker-directed discussions of relevant case studies.

ACCREDITATION

  The AMLI is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians.

DESIGNATION

  The AMLI designates this continuing medical education activity for a maximum of 16 AMA PRA Category 1 Credits^TM.  Physicians should only claim credit commensurate with the extent of their participation in the educational activity.

DISCLOSURE POLICY

  Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by the AMLI are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentations.